A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer-Reference-Cited by-同舟云学术

A randomized, dose–response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer

Published:2012-03 Issue:5 Volume:48 Page:678-686
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Nilsson S.,Strang P.,Aksnes A.K.,Franzèn L.,Olivier P.,Pecking A.,Staffurth J.,Vasanthan S.,Andersson C.,Bruland Ø.S.

Funder

Bayer HealthCare Pharmaceuticals

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference21 articles.

1. Skeletal complications of malignancy;Coleman;Cancer,1997

2. Bone cancer pain;Jimenez-Andrade;Ann N Y Acad Sci,2010

3. Clinical features of metastatic bone disease and risk of skeletal morbidity;Coleman;Clin Cancer Res,2006

4. Pain management in cancer patients with bone metastases remains a challenge;Yau;J Pain Symptom Manage,2004

5. Managing metastatic bone pain: the role of bisphosphonates;Gralow;J Pain Symptom Manage,2007

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Oncogenesis to Theranostics: The Transformative Role of PSMA in Prostate Cancer;Cancers;2024-08-31

2. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

3. Current state of theranostics in metastatic castrate‐resistant prostate cancer;Journal of Medical Imaging and Radiation Oncology;2024-04-17

4. Survey of Main Group Metals and Metalloids in Cancer Treatment;Inorganics;2024-01-12

5. Hemibody Irradiation for Bone Metastases: A Systematic Review and Meta-Analysis;Cureus;2024-01-09